Added to YB: 2024-11-10
Pitch date: 2024-11-10
OPT:US [bullish]
Opthea Limited
-98.32%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.
Market Cap
AUD 466.6M
Pitch Price
AUD 4.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.04
P/E
-1.44
EV/Sales
2.7K
Sector
Biotechnology
Category
N/A
Show full summary:
Opthea Limited Sponsored ADR OPT:US
A summary for this pitch has not been created yet.
Read full article (0 min)